Sun, Jul 13, 2014, 1:58 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Epimmune Inc. (EPMN) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • jgarush jgarush Aug 16, 1999 4:23 PM Flag

    ??????

    SAN DIEGO, Aug. 16 (dbusiness) � Epimmune�s halt
    in production of its anti-inflammatory product and
    the sale of its Glytec technology helped the company
    sharply reduce its net loss for the second
    quarter.

    For the quarter, Epimmune (Nasdaq: EPMN) reported a
    net loss of $900,000, or 17 cents per share, compared
    with a net loss of $5.2 million, or $1.11 per share,
    for the second quarter 1998. Revenue held steady at
    $500,000 for both periods.

    Jamie

 

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Turtle Beach Corporation
NasdaqGMFri, Jul 11, 2014 4:00 PM EDT